{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T10:48:31Z","timestamp":1782211711013,"version":"3.54.5"},"reference-count":34,"publisher":"Walter de Gruyter GmbH","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jpem-2025-0273_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Successful transition from paediatric to adult healthcare is integral in the management of chronic conditions. Osteogenesis imperfecta (OI) is a rare genetic connective tissue disorder affecting the skeleton and several other organ systems, with lifelong implications for clinical management. Consensus guidelines for the transition of patients with OI do not currently exist. We aimed to evaluate our institution\u2019s transition program for patients with OI and identify strengths and weaknesses of the current process.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2025-0273_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Participants were recruited from April to August 2023 for this cross-sectional survey study. Data were collected using a researcher administered questionnaire. Questionnaire responses, coded into positive, negative, and neutral categories, were explored using content analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2025-0273_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>66 participants were included: 64 patients with OI and 2 staff members involved in transition care. Of the 64 patients, 35 were aged 16\u00a0years and older and able to provide responses specifically evaluating the transition period. Of these 35, 26 (74\u202f%) had been transferred to adult care, with 6 (23\u202f%) reporting no ongoing care. Predominantly, challenges and weaknesses of the transition program were identified; lack of knowledge, feeling-ill prepared and being lost during the transition process.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2025-0273_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Early introduction of transition care, a comprehensive transfer tool, future options for adult care and a transition coordinator\/clinic were suggested by participants. Future work involves a prospective study implementing these recommendations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jpem-2025-0273","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T10:11:40Z","timestamp":1782209500000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the transition of young adults with osteogenesis imperfecta: a patient-focused prospective study"],"prefix":"10.1515","author":[{"given":"Lucy","family":"Collins","sequence":"first","affiliation":[{"name":"Department of Endocrinology , Royal Children\u2019s Hospital , Parkville , VIC , Australia"},{"name":"Hormone Research, Murdoch Children\u2019s Research Institute , Royal Children\u2019s Hospital , Parkville , VIC , Australia"},{"name":"Department of Medicine, School of Clinical Sciences , Monash University , Melbourne , VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Lim","sequence":"additional","affiliation":[{"name":"Hormone Research, Murdoch Children\u2019s Research Institute , Royal Children\u2019s Hospital , Parkville , VIC , Australia"},{"name":"Department of Pharmacy , Monash University , Melbourne , VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Alwaheb","sequence":"additional","affiliation":[{"name":"Department of Pharmacy , Monash University , Melbourne , VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie S.S.","family":"Chee","sequence":"additional","affiliation":[{"name":"Department of Pharmacy , Monash University , Melbourne , VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee K.","family":"Chew","sequence":"additional","affiliation":[{"name":"Department of Pharmacy , Monash University , Melbourne , VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni G.R.","family":"Farag","sequence":"additional","affiliation":[{"name":"Department of Pharmacy , Monash University , Melbourne , VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Gurdev","sequence":"additional","affiliation":[{"name":"Department of Pharmacy , Monash University , Melbourne , VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Zacharin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology , Royal Children\u2019s Hospital , Parkville , VIC , Australia"},{"name":"Hormone Research, Murdoch Children\u2019s Research Institute , Royal Children\u2019s Hospital , Parkville , VIC , Australia"},{"name":"Department of Paediatrics , University of Melbourne , Melbourne , VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Simm","sequence":"additional","affiliation":[{"name":"Department of Endocrinology , Royal Children\u2019s Hospital , Parkville , VIC , Australia"},{"name":"Hormone Research, Murdoch Children\u2019s Research Institute , Royal Children\u2019s Hospital , Parkville , VIC , Australia"},{"name":"Department of Paediatrics , University of Melbourne , Melbourne , VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"2026062310083722435_j_jpem-2025-0273_ref_001","doi-asserted-by":"crossref","unstructured":"Cooley, WC, Sagerman, PJ. Supporting the health care transition from adolescence to adulthood in the medical home. Pediatrics 2011;128:182\u2013200. https:\/\/doi.org\/10.1542\/peds.2011-0969.","DOI":"10.1542\/peds.2011-0969"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_002","doi-asserted-by":"crossref","unstructured":"Harden, PN, Walsh, G, Bandler, N, Bradley, S, Lonsdale, D, Taylor, J, et al.. Bridging the gap: an integrated paediatric to adult clinical service for young adults with kidney failure. BMJ: British Med J 2012;344:e3718. https:\/\/doi.org\/10.1136\/bmj.e3718.","DOI":"10.1136\/bmj.e3718"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_003","doi-asserted-by":"crossref","unstructured":"Dugu\u00e9p\u00e9roux, I, Tamalet, A, Sermet-Gaudelus, I, Le Bourgeois, M, G\u00e9rardin, M, Desmazes-Dufeu, N, et al.. Clinical changes of patients with cystic fibrosis during transition from pediatric to adult care. J\u00a0Adolesc Health 2008;43:459\u201365. https:\/\/doi.org\/10.1016\/j.jadohealth.2008.03.005.","DOI":"10.1016\/j.jadohealth.2008.03.005"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_004","doi-asserted-by":"crossref","unstructured":"Rauch, F, Morin, SN. Transition from pediatric to adult health care in osteogenesis imperfecta. Curr Osteoporos Rep 2023;21:426\u201332. https:\/\/doi.org\/10.1007\/s11914-023-00794-7.","DOI":"10.1007\/s11914-023-00794-7"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_005","doi-asserted-by":"crossref","unstructured":"Ross, J, Bowden, MR, Yu, C, Diaz-Thomas, A. Transition of young adults with metabolic bone diseases to adult care. Front Endocrinol 2023;14:1137976. https:\/\/doi.org\/10.3389\/fendo.2023.1137976.","DOI":"10.3389\/fendo.2023.1137976"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_006","doi-asserted-by":"crossref","unstructured":"Garibaldi, N, Besio, R, Dalgleish, R, Villani, S, Barnes, AM, Marini, JC, et al.. Dissecting the phenotypic variability of osteogenesis imperfecta. Dis Model Mech 2022;15. https:\/\/doi.org\/10.1242\/dmm.049398.","DOI":"10.1242\/dmm.049398"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_007","doi-asserted-by":"crossref","unstructured":"Rossi, V, Lee, B, Marom, R. Osteogenesis imperfecta: advancements in genetics and treatment. Curr Opin Pediatr 2019;31:708\u201315. https:\/\/doi.org\/10.1097\/mop.0000000000000813.","DOI":"10.1097\/MOP.0000000000000813"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_008","doi-asserted-by":"crossref","unstructured":"Sillence, DO, Senn, A, Danks, DM. Genetic heterogeneity in osteogenesis imperfecta. J\u00a0Med Genet 1979;16:101\u201316. https:\/\/doi.org\/10.1136\/jmg.16.2.101.","DOI":"10.1136\/jmg.16.2.101"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_009","doi-asserted-by":"crossref","unstructured":"Glorieux, FH, Bishop, NJ, Plotkin, H, Chabot, G, Lanoue, G, Travers, R. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N\u00a0Engl J Med 1998;339:947\u201352. https:\/\/doi.org\/10.1056\/nejm199810013391402.","DOI":"10.1056\/NEJM199810013391402"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_010","doi-asserted-by":"crossref","unstructured":"Astr\u00f6m, E, S\u00f6derh\u00e4ll, S. Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta. Arch Dis Child 2002;86:356\u201364. https:\/\/doi.org\/10.1136\/adc.86.5.356.","DOI":"10.1136\/adc.86.5.356"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_011","doi-asserted-by":"crossref","unstructured":"Rauch, F, Travers, R, Plotkin, H, Glorieux, FH. The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. J\u00a0Clin Investig 2002;110:1293\u20139. https:\/\/doi.org\/10.1172\/jci200215952.","DOI":"10.1172\/JCI0215952"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_012","doi-asserted-by":"crossref","unstructured":"Kobayashi, T, Nakamura, Y, Suzuki, T, Yamaguchi, T, Takeda, R, Takagi, M, et al.. Efficacy and safety of denosumab therapy for osteogenesis imperfecta patients with osteoporosis-case series. J\u00a0Clin Med 2018;7. https:\/\/doi.org\/10.3390\/jcm7120479.","DOI":"10.3390\/jcm7120479"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_013","doi-asserted-by":"crossref","unstructured":"Glorieux, FH, Devogelaer, JP, Durigova, M, Goemaere, S, Hemsley, S, Jakob, F, et al.. BPS804\u00a0anti-sclerostin antibody in adults with moderate osteogenesis imperfecta: results of a randomized phase 2a trial. J\u00a0Bone Min Res 2017;32:1496\u2013504. https:\/\/doi.org\/10.1002\/jbmr.3143.","DOI":"10.1002\/jbmr.3143"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_014","doi-asserted-by":"crossref","unstructured":"Song, IW, Nagamani, SC, Nguyen, D, Grafe, I, Sutton, VR, Gannon, FH, et al.. Targeting TGF-\u03b2 for treatment of osteogenesis imperfecta. J\u00a0Clin Investig 2022;132. https:\/\/doi.org\/10.1172\/jci152571.","DOI":"10.1172\/JCI152571"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_015","doi-asserted-by":"crossref","unstructured":"Dogba, MJ, Rauch, F, Wong, T, Ruck, J, Glorieux, FH, Bedos, C. From pediatric to adult care: strategic evaluation of a transition program for patients with osteogenesis imperfecta. BMC Health Serv Res 2014;14:489. https:\/\/doi.org\/10.1186\/s12913-014-0489-1.","DOI":"10.1186\/s12913-014-0489-1"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_016","doi-asserted-by":"crossref","unstructured":"Isabel Carrier, J, Siedlikowski, M, Chougui, K, Plourde, S-A, Mercier, C, Thevasagayam, G, et al.. A best practice initiative to optimize transfer of young adults with osteogenesis imperfecta from child to adult healthcare services. Clin Nurse Spec 2018;32:323\u201335. https:\/\/doi.org\/10.1097\/nur.0000000000000407.","DOI":"10.1097\/NUR.0000000000000407"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_017","doi-asserted-by":"crossref","unstructured":"Grasemann, C, Wernsmann, J, Appelman-Dijkstra, NM, Morgan, C, Sylvest, TT, Raimann, A, et al.. Transition care for young persons with rare bone mineral conditions: a consensus recommendation from the ECTS rare bone disease action group. Calcif Tissue Int 2025;116:73. https:\/\/doi.org\/10.1007\/s00223-025-01382-w.","DOI":"10.1007\/s00223-025-01382-w"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_018","doi-asserted-by":"crossref","unstructured":"Celli, L, Garrelfs, MR, Sakkers, RJB, Elting, MW, Celli, M, B\u00f6kenkamp, A, et al.. Adapting to adulthood: a review of transition strategies for osteogenesis imperfecta. Calcif Tissue Int 2024;115:960\u201375. https:\/\/doi.org\/10.1007\/s00223-024-01305-1.","DOI":"10.1007\/s00223-024-01305-1"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_019","doi-asserted-by":"crossref","unstructured":"Ranganathan, P, Caduff, C, Frampton, CMA. Designing and validating a research questionnaire\u00a0\u2013\u00a0part 2. Perspect Clin Res 2024;15:42\u20135. https:\/\/doi.org\/10.4103\/picr.picr_318_23.","DOI":"10.4103\/picr.picr_318_23"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_020","doi-asserted-by":"crossref","unstructured":"Harris, PA, Taylor, R, Thielke, R, Payne, J, Gonzalez, N, Conde, JG. Research electronic data capture (REDCap)\u00a0\u2013\u00a0a metadata-driven methodology and workflow process for providing translational research informatics support. J\u00a0Biomed Inf 2009;42:377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_021","doi-asserted-by":"crossref","unstructured":"Michalovic, A, Anderson, C, Thorstad, K, Rauch, F, Tsimicalis, A. Exploring the perceived self-management needs of young adults with osteogenesis imperfecta. Clin Nurse Spec 2020;34:99\u2013106. https:\/\/doi.org\/10.1097\/nur.0000000000000517.","DOI":"10.1097\/NUR.0000000000000517"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_022","doi-asserted-by":"crossref","unstructured":"Coyne, I, Sheehan, AM, Heery, E, While, AE. Improving transition to adult healthcare for young people with cystic fibrosis: a systematic review. J\u00a0Child Health Care 2017;21:312\u201330. https:\/\/doi.org\/10.1177\/1367493517712479.","DOI":"10.1177\/1367493517712479"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_023","doi-asserted-by":"crossref","unstructured":"Lopez, C, Glassberg, B, Dembar, A, Riasat, M, Chan, A, Govindarajulu, U, et al.. Transition of care in CHD: a single-centre experience: an enigma remains. Cardiol Young 2023:1\u20137. https:\/\/doi.org\/10.1017\/s1047951123002548.","DOI":"10.1017\/S1047951123002548"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_024","doi-asserted-by":"crossref","unstructured":"Zahra, B, Sastry, A, Freel, M, Donaldson, M, Mason, A. Turner syndrome transition clinic in the west of Scotland: a perspective. Front Endocrinol 2023;14:1233723. https:\/\/doi.org\/10.3389\/fendo.2023.1233723.","DOI":"10.3389\/fendo.2023.1233723"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_025","doi-asserted-by":"crossref","unstructured":"Sheppard, S, Hellemann, G, Lebensburger, J, Kanter, J. Assessing barriers and facilitators to transition in sickle cell disease care prior to implementation of a formalized program. Pediatr Blood Cancer 2023;70:e30160. https:\/\/doi.org\/10.1002\/pbc.30160.","DOI":"10.1002\/pbc.30160"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_026","doi-asserted-by":"crossref","unstructured":"Schraeder, K, Allemang, B, Scott, C, McBrien, K, Dimitropoulos, G, Felske, A, et al.. Primary care during the transition to adult care for adolescents involved with pediatric specialty services: a scoping review protocol. Syst Rev 2021;10:46. https:\/\/doi.org\/10.1186\/s13643-021-01593-w.","DOI":"10.1186\/s13643-021-01593-w"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_027","doi-asserted-by":"crossref","unstructured":"Shulman, R, Shah, BR, Fu, L, Chafe, R, Guttmann, A. Diabetes transition care and adverse events: a population-based cohort study in Ontario, Canada. Diabet Med 2018;35:1515\u201322. https:\/\/doi.org\/10.1111\/dme.13782.","DOI":"10.1111\/dme.13782"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_028","doi-asserted-by":"crossref","unstructured":"Toulany, A, Stukel, TA, Kurdyak, P, Fu, L, Guttmann, A. Association of primary care continuity with outcomes following transition to adult care for adolescents with severe mental illness. JAMA Netw Open 2019;2:e198415. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.8415.","DOI":"10.1001\/jamanetworkopen.2019.8415"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_029","doi-asserted-by":"crossref","unstructured":"Gabriel, P, McManus, M, Rogers, K, White, P. Outcome evidence for structured pediatric to adult health care transition interventions: a systematic review. J\u00a0Pediatr 2017;188:263\u20139.e15. https:\/\/doi.org\/10.1016\/j.jpeds.2017.05.066.","DOI":"10.1016\/j.jpeds.2017.05.066"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_030","doi-asserted-by":"crossref","unstructured":"Crowley, R, Wolfe, I, Lock, K, McKee, M. Improving the transition between paediatric and adult healthcare: a systematic review. Arch Dis Child 2011;96:548\u201353. https:\/\/doi.org\/10.1136\/adc.2010.202473.","DOI":"10.1136\/adc.2010.202473"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_031","doi-asserted-by":"crossref","unstructured":"Rosen, DS, Blum, RW, Britto, M, Sawyer, SM, Siegel, DM. Transition to adult health care for adolescents and young adults with chronic conditions: position paper of the society for adolescent medicine. J\u00a0Adolesc Health 2003;33:309\u201311. https:\/\/doi.org\/10.1016\/s1054-139x(03)00208-8.","DOI":"10.1016\/S1054-139X(03)00208-8"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_032","doi-asserted-by":"crossref","unstructured":"Jeong, S, Chougui, K, Mercier, C, Wong, T, Lafrance, ME, Gagnon, V, et al.. Development of the Good2Go MyHealth passport for individuals with osteogenesis imperfecta: a knowledge-synthesis study. Int J Orthop Trauma Nurs 2019;33:27\u201334. https:\/\/doi.org\/10.1016\/j.ijotn.2018.11.005.","DOI":"10.1016\/j.ijotn.2018.11.005"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_033","doi-asserted-by":"crossref","unstructured":"Tsimicalis, A, Stinson, J, Thorstad, K, Rauch, F, Hamdy, R, Chougui, K, et al.. The design, development, and usability testing of an eHealth program for youths with osteogenesis imperfecta: protocol for a 2-phase user-centered mixed methods study. JMIR Res Protoc 2023;12:e47524. https:\/\/doi.org\/10.2196\/47524.","DOI":"10.2196\/47524"},{"key":"2026062310083722435_j_jpem-2025-0273_ref_034","doi-asserted-by":"crossref","unstructured":"Munns, CF, Yoo, H-W, Jalaludin, MY, Vasanwala, R, Chandran, M, Rhee, Y, et al.. Asia-Pacific consensus recommendations on X-linked hypophosphatemia: diagnosis, multidisciplinary management, and transition from pediatric to adult care. JBMR Plus 2023;7:e10744. https:\/\/doi.org\/10.1002\/jbm4.10744.","DOI":"10.1002\/jbm4.10744"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2025-0273\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2025-0273\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T10:12:51Z","timestamp":1782209571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2025-0273\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":34,"alternative-id":["10.1515\/jpem-2025-0273"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2025-0273","relation":{},"ISSN":["0334-018X","2191-0251"],"issn-type":[{"value":"0334-018X","type":"print"},{"value":"2191-0251","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]}}}